Term Loans - Schedule of Term Loan Obligations (Details) - USD ($) $ in Thousands |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Long-Term Debt, Current and Noncurrent [Abstract] | ||
| Principal Balance | $ 150,000 | $ 125,000 |
| Unamortized Debt Financing Costs | (4,215) | (3,494) |
| Exit Consideration | 311 | |
| Balance, Net | 146,096 | 121,506 |
| New Pharmakon Term Loans | Line of Credit | Secured Debt | ||
| Long-Term Debt, Current and Noncurrent [Abstract] | ||
| Principal Balance | 150,000 | |
| Unamortized Debt Financing Costs | (4,215) | |
| Exit Consideration | 311 | |
| Balance, Net | $ 146,096 | |
| Prior Pharmakon Term Loans | Line of Credit | Secured Debt | ||
| Long-Term Debt, Current and Noncurrent [Abstract] | ||
| Principal Balance | 125,000 | |
| Unamortized Debt Financing Costs | (3,494) | |
| Balance, Net | $ 121,506 |
| X | ||||||||||
- Definition Debt Instrument, Exit Consideration No definition available.
|
| X | ||||||||||
- Definition Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|